All news

Coca-Cola to settle some Vitaminwater deceptive advertising lawsuits

Settlement offers injunctive, but not monetary, relief (Coke required to amend labels but consumers won't get any money)

Coca-Cola agrees to settle 'copycat' Vitaminwater deceptive advertising lawsuits, but CSPI still on the warpath

By Elaine Watson

Coca-Cola has agreed to settle a series of 'copycat' lawsuits accusing it of deceptively marketing Vitaminwater. But the lawsuit that inspired them all - filed by the Center for Science in the Public Interest in 2009 - is still pending, as the...

FDA removes another DMAA-containing supplement from market

FDA removes another DMAA-containing supplement from market

By Hank Schultz

Like a bad penny, DMAA keeps cropping up in the market.  In the most recent instance,  a company called Regenaca Worldwide has recalled diet capsules that contain the ingredient, which FDA has banned from the market.

Latest heart health studies look at oils, vitamins, algae, polyphenols

Special edition: The latest on cardiovascular health research

Latest heart health studies look at oils, vitamins, algae, polyphenols

By Hank Schultz

Rising rates of cardiovascular disease was once the heart of the matter when identifying what was going on with Western diets and the risk posed by modern lifestyles. The specter of dying younger than one ought from a heart attack has receded some in...

Red Queen theory argues that despite inducing greater and more speedy responses from rivals, the most active and aggressive firms are the best performers.

Red Queen Rules: Understanding nutra space acquisition and evolution

By Dr Matthew Jones

By analysing the long-lasting commitments and acquisition activity of major companies Dr Matthew Jones at CPL Business Consultants uses the Red Queen theory to develop an understanding of their corporate mind-set and appetite for acquisitions and partnerships...

Research raises questions about synbiotic definitions, says probiotics firm.

Is strain-specificity of prebiotics a limitation or opportunity?

By Annie Harrison-Dunn

Strain-specificity of prebiotics is not a limiting factor but rather an opportunity to develop the ‘next generation’ of synbiotic formulations, says Winclove Probiotics in response to unflattering results of a study on synbiotics. 

Integrated strategy helps Vitamin Shoppe power through soft patch

Integrated strategy helps Vitamin Shoppe power through soft patch

By Hank Schultz

Vitamin Shoppe, Inc. posted increased sales in the second quarter of its 2014 fiscal year, in line with analysts’ expectations.  The company fell slightly short of earnings expectations as the company dealt with softness that has affected the supplement...

China's proposed food safety overhaul lacks clarity and detail, NPA says

China's proposed food safety overhaul lacks clarity and detail, NPA says

By Hank Schultz

China’s proposed changes in its food safety regulations, which also govern dietary supplements, are long on aspiration and short on specifics. That’s the opinion expressed by the Natural Products Association in comments the organization submitted to Chinese...

DSM:

DSM and Merck form high-end folate alliance

By Shane STARLING

DSM Nutritional Products (DNP) is not abandoning its folic acid (vitamin B9) offering but has added a high-end, folate form aimed at global supplement and food makers in a deal with Merck in Switzerland.

DSM Q2 nutrition profits slip 11% as key markets struggle

DSM Q2 nutrition profits slip 11% as key markets struggle

By Shane STARLING

Sales slipped 6% and net profits 11% in Q2 for DSM’s human and animal nutrition arm as adverse currency movements, a slow US vitamins and omega-3 food supplements market and the Asian botulism infant formula scare affected earnings.

Does vitamin D belong on the Nutrition Facts panel?

NYU professor questions supplements; vitamin D expert supports efficacy of oral forms

Does vitamin D belong on the Nutrition Facts panel?

By Maggie Hennessy

FDA proposals to list "added sugars" on the Nutrition Facts panel have already generated heated debate, so it's unsurprising that its plan to include vitamin D is proving equally controversial, with critics claiming it could encourage over-consumption...

Fallout in China from Nu Skin affair depresses Usana's Q2 results

Fallout in China from Nu Skin affair depresses Usana's Q2 results

By Hank Schultz

Usana Health Sciences reported flat net sales  in the second quarter of its 2014 fiscal year.  Issues in China caused the company to miss analysts’ estimates for sales and earnings, and the company’s share price took a plunge as a result.

MYOS Corp. grows market for myostatin inhibitor beyond the gym

MYOS Corp. grows market for myostatin inhibitor beyond the gym

By Hank Schultz

Myos Corporation has built the market for its myostatin-inhibiting ingredient Fortetropin beyond the gym and into the offices of physician groups treating elderly patients. To secure the supply for the ingredeint the company has extending a manufacturing...

Follow us

Products

View more

Webinars